Teleflex Incorporated (NYSE:TFX) Shareholders to Get $0.34 Quarterly Dividend

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend on Thursday, November 5th. Investors of record on Monday, November 16th will be paid a dividend of $0.34 per share by the medical technology company on Thursday, December 31st. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, November 16th.

Teleflex has a dividend payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Teleflex to earn $10.89 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 12.5%.

Teleflex Stock Performance

TFX traded up $1.98 on Thursday, hitting $151.85. 1,417,531 shares of the company traded hands, compared to its average volume of 784,145. The company has a 50 day moving average of $131.62 and a 200-day moving average of $125.60. Teleflex has a 12-month low of $100.18 and a 12-month high of $156.67. The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. The stock has a market capitalization of $6.43 billion, a PE ratio of -6.52, a PEG ratio of 0.94 and a beta of 0.85.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, November 5th. The medical technology company reported $2.63 EPS for the quarter, beating the consensus estimate of $1.90 by $0.73. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%. The business had revenue of $567.80 million during the quarter, compared to analysts’ expectations of $565.52 million. During the same period last year, the firm earned $3.67 EPS. The company’s quarterly revenue was up .1% compared to the same quarter last year. Sell-side analysts anticipate that Teleflex will post 7.22 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. UBS Group lifted their price target on shares of Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. Truist Financial cut their price objective on Teleflex from $150.00 to $142.00 and set a “hold” rating on the stock in a research report on Wednesday, October 14th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Monday, September 21st. Piper Sandler reissued an “overweight” rating and set a $169.00 price target (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. Finally, Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Teleflex presently has an average rating of “Moderate Buy” and a consensus price target of $154.40.

About Teleflex

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.